Manuel Sánchez-Cánovas

13PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 30, 2026
Venous and arterial thromboembolic events associated with osimertinib in patients with lung cancer: a study by the thrombosis and cancer group of the spanish society of medical oncology (SEOM).

|Nov 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Mercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar

|Sep 07, 2025
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Manuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo

|Jun 21, 2024
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Manuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei

|Jun 12, 2024
Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

Manuel Sánchez Cánovas, Esmeralda García Torralba, Noel Blaya Boluda

|Jan 29, 2024
Endoscopic intervention as a decisive tool in the prognosis of cancer patients.

Manuel Sánchez Cánovas, Javier López Robles, Marina Lozano Ros

Pageof 3

Frequent Collaborators

2 joint publications

Alberto Carmona-Bayonas

2 joint publications

Eva Martínez de Castro

2 joint publications

Vicente Vicente

1 joint publications

C Carriles